Geode Capital Management’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-255,254
| Closed | -$508K | – | 4516 |
|
|
2025
Q2 | $508K | Sell |
255,254
-353,679
| -58% | -$647K | ﹤0.01% | 3547 |
|
|
2025
Q1 | $883K | Buy |
608,933
+4,981
| +0.8% | +$9.21K | ﹤0.01% | 3349 |
|
|
2024
Q4 | $1.25M | Sell |
603,952
-23,717
| -4% | -$44.5K | ﹤0.01% | 3286 |
|
|
2024
Q3 | $1.1M | Sell |
627,669
-80,362
| -11% | -$206K | ﹤0.01% | 3319 |
|
|
2024
Q2 | $10.2M | Buy |
708,031
+86,214
| +14% | +$1.18M | ﹤0.01% | 2313 |
|
|
2024
Q1 | $10.3M | Buy |
621,817
+30,672
| +5% | +$491K | ﹤0.01% | 2308 |
|
|
2023
Q4 | $9.49M | Buy |
591,145
+172,852
| +41% | +$2.3M | ﹤0.01% | 2378 |
|
|
2023
Q3 | $5.63M | Buy |
418,293
+60,971
| +17% | +$858K | ﹤0.01% | 2579 |
|
|
2023
Q2 | $6.14M | Buy |
357,322
+70,046
| +24% | +$1.09M | ﹤0.01% | 2581 |
|
|
2023
Q1 | $4.75M | Buy |
287,276
+9,470
| +3% | +$152K | ﹤0.01% | 2645 |
|
|
2022
Q4 | $4.65M | Buy |
277,806
+50,217
| +22% | +$907K | ﹤0.01% | 2707 |
|
|
2022
Q3 | $3.89M | Buy |
227,589
+8,082
| +4% | +$118K | ﹤0.01% | 2798 |
|
|
2022
Q2 | $2.4M | Buy |
+219,507
| New | +$2.61M | ﹤0.01% | 3052 |
|
Geode Capital Management's HLVX Position: Q3 2025 in Review
Geode Capital Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 255,254 shares — an estimated $508K sold.
Geode Capital Management first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $10.3M in Q1 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- Geode Capital Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- Geode Capital Management sold 255,254 HilleVax shares in Q3 2025, an estimated $508K.
- Geode Capital Management first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
- Geode Capital Management's HilleVax position peaked at $10.3M in Q1 2024.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.